Model
Edge
Acrivon Therapeutics Inc.
0001841088
Filing type
4
Filing date
Apr 20, 2026
Updated
Apr 21, 2026 ยท 3:05 PM
Copy reference
Filing
4
Statement of Changes in Beneficial Ownership